LFMD vs. OSUR, ADPT, LXEO, ITOS, CYH, RVNC, CDNA, PEPG, OCGN, and ZYXI
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include OraSure Technologies (OSUR), Adaptive Biotechnologies (ADPT), Lexeo Therapeutics (LXEO), iTeos Therapeutics (ITOS), Community Health Systems (CYH), Revance Therapeutics (RVNC), CareDx (CDNA), PepGen (PEPG), Ocugen (OCGN), and Zynex (ZYXI). These companies are all part of the "medical" sector.
LifeMD (NASDAQ:LFMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk.
OraSure Technologies received 523 more outperform votes than LifeMD when rated by MarketBeat users. Likewise, 69.86% of users gave OraSure Technologies an outperform vote while only 68.57% of users gave LifeMD an outperform vote.
LifeMD has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500.
OraSure Technologies has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.
OraSure Technologies has a net margin of 13.23% compared to LifeMD's net margin of -14.01%. OraSure Technologies' return on equity of 14.50% beat LifeMD's return on equity.
LifeMD presently has a consensus price target of $10.40, suggesting a potential downside of 4.50%. OraSure Technologies has a consensus price target of $6.38, suggesting a potential upside of 15.28%. Given OraSure Technologies' higher probable upside, analysts clearly believe OraSure Technologies is more favorable than LifeMD.
In the previous week, OraSure Technologies had 1 more articles in the media than LifeMD. MarketBeat recorded 4 mentions for OraSure Technologies and 3 mentions for LifeMD. LifeMD's average media sentiment score of 0.00 equaled OraSure Technologies'average media sentiment score.
35.5% of LifeMD shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 18.9% of LifeMD shares are owned by company insiders. Comparatively, 3.4% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
OraSure Technologies beats LifeMD on 12 of the 17 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
